<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: We discuss the clinical, laboratory findings and treatment of a boy who developed Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) after renal transplant and some issues about <z:hpo ids='HP_0005523'>lymphoproliferative disorders</z:hpo> after transplantation </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: A 6-year-old boy with <z:e sem="disease" ids="C0403402" disease_type="Disease or Syndrome" abbrv="">Drash syndrome</z:e> developed disseminated Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> 38 months after transplantation for <z:hpo ids='HP_0000083'>renal failure</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Immunosuppressive therapy had consisted of <z:chebi fb="2" ids="8378">prednisolone</z:chebi> and <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Polychemotherapy was initiated </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Polychemotherapy induced rapid and complete remission of the disease without major side effects despite the renal transplant allograft and prolonged immunosuppression </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSIONS: A child with posttransplantation B-cell high-grade <z:hpo ids='HP_0002665'>lymphoma</z:hpo> can be successfully treated with the same chemotherapy regimen used for ordinary cases </plain></SENT>
</text></document>